Price$6.83-0.18 (-2.57%)
01:45 PM05:45 PM
News · 26 weeks23+450%
2025-12-072026-05-31
Mix1890d
- Insider7(39%)
- SEC Filings6(33%)
- Other3(17%)
- Earnings2(11%)
Latest news
25 items- INSIDEREVP, Operations Herman Joan M sold $233,730 worth of shares (29,202 units at $8.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 807,009 units (SEC Form 4)4 - Paysign, Inc. (0001496443) (Issuer)
- PRPaysign, Inc. to Present at the Planet MicroCap Las Vegas 2026Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Planet MicroCap Las Vegas 2026 powered by MicroCapClub to be held June 16-18, 2026, at the Bellagio Resort & Casino located on the Las Vegas Strip. Paysign's CFO, Jeff Baker, is scheduled to present on Wednesday, June 17, at 11:30 a.m. Pacific time. Investors may visit the event website for additional information, including registration, agenda and webcasts. About Paysign Paysign, Inc. (NASDAQ: PAYS) operates at the intersec
- INSIDERChief Legal Officer Strobo Robert covered exercise/tax liability with 39,235 shares and was granted 66,667 shares, increasing direct ownership by 8% to 354,632 units (SEC Form 4) (for withholding tax)4 - Paysign, Inc. (0001496443) (Issuer)
- INSIDEREVP, Operations Herman Joan M sold $158,038 worth of shares (22,534 units at $7.01) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 813,989 units (SEC Form 4)4 - Paysign, Inc. (0001496443) (Issuer)
- PRPaysign, Inc. to Present at the Barrington Research Virtual Spring Investment ConferencePaysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the 20th Annual Barrington Research Virtual Spring Investment Conference taking place today, May 27, 2026. Paysign's CFO, Jeff Baker, will be giving one-on-one presentations throughout the day. Investors may visit the event website for additional information, including registration and agenda. About Paysign Paysign, Inc. (NASDAQ: PAYS) operates at the intersection of fintech and healthcare, integrating advanced payment processin
- INSIDERCEO Newcomer Mark was granted 133,334 shares and covered exercise/tax liability with 78,701 shares, increasing direct ownership by 0.61% to 9,005,361 units (SEC Form 4) to satisfy tax liability4 - Paysign, Inc. (0001496443) (Issuer)
- INSIDERChief Payments Officer Lanford Matthew Louis was granted 22,222 shares and covered exercise/tax liability with 12,755 shares, increasing direct ownership by 5% to 190,165 units (SEC Form 4) (tax liability)4 - Paysign, Inc. (0001496443) (Issuer)
- INSIDEREVP, Operations Herman Joan M was granted 11,111 shares and covered exercise/tax liability with 6,171 shares, increasing direct ownership by 0.59% to 836,523 units (SEC Form 4) (tax liability)4 - Paysign, Inc. (0001496443) (Issuer)
- SECSEC Form 10-Q filed by Paysign Inc.10-Q - Paysign, Inc. (0001496443) (Filer)
- SECPaysign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Paysign, Inc. (0001496443) (Filer)
- PRPaysign's Patient Affordability Drives 51% Revenue Growth and Significant Margin Expansion for First Quarter 2026Mix Shift Continues to Deliver Expansion in Gross and Operating Margin Strong Balance Sheet Enables Continued Investment for Profitable Growth Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the first quarter 2026. First Quarter 2026 Financial Highlights First quarter 2026 revenues of $28.04 million, up 50.8% from first quarter 2025 First quarter 2026 pharma revenue increased to $15.68 million, an increase of 81.9% versus first quarter 2025; added 45 net patient affordabili
- INSIDEREVP, Operations Herman Joan M sold $46,737 worth of shares (6,667 units at $7.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.80% to 831,583 units (SEC Form 4)4 - Paysign, Inc. (0001496443) (Issuer)
- PRPaysign to Host First Quarter 2026 Earnings CallPaysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss first quarter 2026 earnings at 5:00 p.m. Eastern time on Tuesday, May 12, 2026. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.6853 or +1.201.612.7415 Conference ID: 13760115 The replay will be available until August 12, 2026. To register as a financial professional in order to ask questions during the call, please email ir@paysign.com no later than 5:00 p.m.
- SECSEC Form DEFA14A filed by Paysign Inc.DEFA14A - Paysign, Inc. (0001496443) (Filer)
- SECSEC Form DEF 14A filed by Paysign Inc.DEF 14A - Paysign, Inc. (0001496443) (Filer)
- SECSEC Form 10-K filed by Paysign Inc.10-K - Paysign, Inc. (0001496443) (Filer)
- SECPaysign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Paysign, Inc. (0001496443) (Filer)
- PRPaysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin ExpansionMix Shift Drives Gross and Operating Margin Expansion Strong Balance Sheet Enables Continued Investment for Profitable Growth Paysign, Inc. (NASDAQ:PAYS), a leading provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the fourth quarter and full-year 2025. Full-Year Financial Highlights Full-year 2025 total revenues of $82.0 million, up 40.5% from 2024 Total net plasma center count increased by 115 during 2025, exiting the year with 595 centers, contributing to a 4.0% increase in plasma revenue versus the same period
- INSIDERChief Financial Officer Baker Jeffery Bradford covered exercise/tax liability with 26,055 shares and converted options into 60,000 shares, increasing direct ownership by 10% to 386,218 units (SEC Form 4)4 - Paysign, Inc. (0001496443) (Issuer)
- PRPaysign to Host Fourth Quarter and Full Year 2025 Earnings CallPaysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss fourth quarter and full year 2025 earnings at 5:00 p.m. Eastern time on Tuesday, March 24, 2026. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.6853 or +1.201.612.7415 Conference ID: 13758162 The replay will be available until June 24, 2026. To register as a financial professional in order to ask questions during the call, please email ir@paysign.com no later
- PRPaysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth ConferencePaysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format. The focus of the virtual conference is to feature one-on-one and small group meetings with emerging companies in technology, industrial growth and consumer sectors. Paysign's Chief Financial Officer, Jeff Baker, will host one-on-one meetings on Tuesday, February 3. Investors interested in registering may contact their Oppe
- PRPaysign, Inc. Announces 2025 Performance Analysis of Patient Affordability SolutionsDynamic Business Rules Demonstrates the Company's Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions and integrated payment processing for the life sciences industries, today announced its annual performance analysis of pharmaceutical copay programs. The company added 55 programs during 2025, exiting the year with 131 programs – many incorporating Paysign's Dynamic Business Rules feature, which saved pharmaceutical clients more than $325 million by mitigating the harmful financial impact of copay maximizers on patients and program sponso
- INSIDERChief Legal Officer Strobo Robert sold $109,400 worth of shares (20,000 units at $5.47), decreasing direct ownership by 6% to 327,290 units (SEC Form 4)4 - Paysign, Inc. (0001496443) (Issuer)
- PRPaysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor ConferencePaysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas. The conference is an annual invitation-only event, featuring quality public companies to interact with top institutional investors. The format has been designed to give attendees direct access to senior management via one-on-one and group meeting formats. Paysign's Chief Financial Officer, Jeff Baker,
- SECSEC Form 10-Q filed by Paysign Inc.10-Q - Paysign, Inc. (0001496443) (Filer)
PAYS FAQ
6 questionsWhat does Paysign Inc. do?
PaySign, Inc. provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. The company offers various services, including transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a proprietary card-processing platform. It also develops prepaid card solutions for corporate incentive and rewards, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance; and payroll or...Where does PAYS stock trade?
Paysign Inc. (PAYS) is listed on NASDAQ.What sector and industry is PAYS in?
Paysign Inc. operates in the Technology sector, EDP Services industry.What are analysts saying about PAYS?
Paysign Inc. has had 6 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $600.00 price target on 2024-12-20. Recent price targets range from $350.00 to $600.00.What companies are similar to PAYS?
Notable peers in the same industry include NEE (NextEra Energy Inc.), PDD (PDD Holdings Inc.), INFY (Infosys Limited), WDAY (Workday Inc.), DASH (DoorDash Inc.). Compare PAYS side-by-side with any of them on Quantisnow.How can I track PAYS on Quantisnow?
Quantisnow aggregates Paysign Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PAYS to receive live email and push alerts on every new disclosure.